Skip to content

Author

Lamprini Skorda

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Effect of clarithromycin on the circulating inflammatory proteome in community-acquired pneumonia: a secondary analysis of the ACCESS trial.

BACKGROUND The ACCESS randomized double-blind controlled trial in hospitalized adults with community-acquired pneumonia (CAP) showed that adding clarithromycin to standard-of-care therapy accelerated clinical recovery within the first 72 hours after the commencement of treatment and reduced progression to organ dysfunc...

Emmanouil Stylianakis, K. Tsiakos, Georgios Niotis et al. · 0 citations
Open access Sep 2026

The Divergent Metabolomic Landscape of COVID-19 and Community-Acquired Pneumonia

Extensive divergence was observed in the metabolomic landscape of patients with COVID-19 or CAP, underscoring the disease-specific metabolic adaptations and providing potential targets for diagnostic and therapeutic development.

Vassiliki Rapti, S. Foutadakis, Nikolaos Kakavoulis et al. · 1 citation · ⚡1

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.